Evaluation of the Quality of Life of Patients Requiring Intestinal Cleansing Using Oral Medications to Imaging Procedure by Patient Reported Outcome
- Conditions
- Bowel Preparation
- Interventions
- Drug: polyethylene glycol + Electrolytes
- Registration Number
- NCT02536729
- Lead Sponsor
- Fundación Salutia
- Brief Summary
Objective: The primary objective of this study is to assess the quality of life of people treated with oral phosphate compared with polyethylene glycol + electrolytes to imaging procedures, according to the outcome variables reported by patients.
Type of study: A non-interventional observational analytic prospective cohort study.
Sample: We will include people who need bowel cleansing for the realization of imaging tests
Exposures: - oral sodium phosphate normal regimen
* Oral sodium phosphate with modified diet
* Polyethylene Glycol + electrolytes
Follow-up time: 8 days after the bowel preparation
Outcomes: Boston Scale measure Safety Differences between groups in blood test (Sodium, Potassium, Calcium)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 600
- Patients which have order for an imaging procedure that requires bowel cleansing
- Older than 18 years and younger than 65 years old
- Accept to participate in this study
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Oral Sodium Phosphate - Normal preparation Oral Sodium Phosphate - Normal preparation Oral sodium phospate exposure with special diet (Liquid) Oral Sodium Phosphate - Modified preparation Oral sodium phosphate - Modified Preparation Oral sodium phospate exposure with special diet (Liquid), but the participant can normally lunch the day before the test polyethylene glycol + Electrolytes polyethylene glycol + Electrolytes polyethylene glycol + Electrolytes exosure with special diet (Liquid)
- Primary Outcome Measures
Name Time Method Boston scale for bowel cleansing 2 days
- Secondary Outcome Measures
Name Time Method Blood Sodium 8 days Number of adverse events 8 days Blood Calcium 8 days Blood Phosphorus 8 days Quality of life 8 days Quality of life measured with EQ5D-3L scale
Blood creatinine 8 days Blood urea nitrogen (BUN) 8 days Blood Potassium 8 days